Region: United States
Category: Life Sciences

United States Life Sciences

(3,934 reports matching your criteria)
  • Therapeutic Respiratory Devices

    ... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More

  • Nursing Education Market in US 2025-2029

    ... the nursing education market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More

  • Transcatheter Heart Valves

    ... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More

  • Generic Drugs

    ... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More

  • Hepatitis B Vaccines

    ... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More

  • Multi-Parameter Patient Monitoring Equipment

    ... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Portable Device, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$12.8 Billion by the ... Read More

  • Blood Transfusion Diagnostics

    ... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More

  • Endometrial Ablation Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More

  • Nail Care

    ... CAGR of 2.6% over the analysis period 2024-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More

  • Fibrin Sealants

    ... CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the ... Read More

  • Office Administrative Services

    ... at a CAGR of 7.9% over the analysis period 2024-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$62.1 Billion by the end ... Read More

  • Whole Exome Sequencing

    ... at a CAGR of 20.2% over the analysis period 2024-2030. Whole Exome Sequencing Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the ... Read More

  • Intrauterine Devices

    ... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More

  • Library Furniture

    ... CAGR of 8.7% over the analysis period 2024-2030. Tables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.9 Billion by the end of the analysis period. ... Read More

  • Long-Term Care

    ... CAGR of 5.5% over the analysis period 2024-2030. Public Payer, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Trillion by the end of the analysis ... Read More

  • Pyrogen Testing

    ... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More

  • Sleeping Aids

    ... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More

  • Produce Packaging Trays

    ... at a CAGR of 4.1% over the analysis period 2024-2030. Growers / Shippers End-Use, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.0 Billion by the ... Read More

  • Analytical Laboratory Services

    ... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More

  • Clot Management Devices

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end ... Read More

  • Genotyping

    ... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More

  • Herpes Marker Testing

    ... at a CAGR of 4.9% over the analysis period 2024-2030. Antibody / Antigen-Based Kits, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$332.9 Million by the ... Read More

  • Photography Equipment

    ... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More

  • Polyphenols

    ... 7.2% over the analysis period 2024-2030. Functional Beverages Application, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$855.9 Million by the end of the analysis period. ... Read More

  • In-Vitro Fertilization

    ... CAGR of 8.0% over the analysis period 2024-2030. In-Vitro Fertilization Equipment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$684.2 Million by the end of the ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings